Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Photodermatol Photoimmunol Photomed ; 34(6): 405-414, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29974533

RESUMEN

BACKGROUND/PURPOSE: Skin commensal bacteria have been described to help orchestrate skin homeostasis, signaling through innate immunity pathways. This study for the first time aimed at studying the relationship between skin commensals and melanocytes after UVB exposure. METHODS: An in vitro UVB radiation model with normal human epidermal melanocytes (NHMs) and skin commensal bacteria supernatant from Staphylococcus epidermidis and Propionibacterium acnes was established. Melanocytes DNA damage, cyclobutane pyrimidine dimers (CPD), and cellular proliferation marker Ki-67 were measured by ELISA and immunofluorescence staining. Cell apoptosis was assessed by flow cytometry and PCR array and RT-qPCR. RESULTS: Normal human epidermal melanocytes are able to survive and proliferate while bearing DNA damage after UVB radiation. Skin commensal bacteria S. epidermidis and its by-product LTA promote melanocytes survival by inducing upregulation of TRAF1, CASP14, CASP5, and TP73. On the other hand, P. acnes can inhibit UVB-irradiated melanocytes survival by increasing apoptosis. CONCLUSION: Our studies show different aspects of commensal activity on melanocytes during irradiation. The possible balance achieved by the different skin commensal can influence NHM potential to become cancer cells.


Asunto(s)
Apoptosis/efectos de la radiación , Daño del ADN , Melanocitos , Propionibacterium acnes/metabolismo , Piel , Staphylococcus epidermidis/metabolismo , Rayos Ultravioleta/efectos adversos , Adulto , Supervivencia Celular/efectos de la radiación , Femenino , Humanos , Masculino , Melanocitos/metabolismo , Melanocitos/microbiología , Melanocitos/patología , Piel/metabolismo , Piel/microbiología , Piel/patología
2.
Anal Chem ; 88(15): 7591-6, 2016 08 02.
Artículo en Inglés | MEDLINE | ID: mdl-27338148

RESUMEN

Cervicovaginal fluid plays an important role in the detection of many female genital diseases, but the lack of suitable collection devices in the market severely challenges test success rate. Appropriate clinical sampling devices for cervicovaginal fluid collection would help physicians detect diseases and disease states more rapidly, efficiently, and accurately. The objective of this study was to develop a readily usable sampling collection device that would eliminate macromolecular interference and accurately provide specimens for further studies. This study was designed to develop an effective device to collect cervicovaginal fluid from women with symptoms of endometrial lesions, women appearing in the clinic for a routine Papanicolaou smear, and/or women seeking a routine gynecologic checkup. Paper-based assay, ELISA, and qNano were used to provide accurate diagnoses. A total of 103 patients successfully used the developed device to collect cervicovaginal fluid. Some of the collected specimens were used to detect glycogen, lactate, and pH for determining pathogen infection. Other specimen samples were tested for the presence of female genital cancer by comparing interleukin 6 concentration and microvesicle concentration. We proposed a noninvasive screening test for the diagnosis of female genital diseases using a dual-material collection device. The outer, nonwoven fabric portion of this device was designed to filter macromolecules, and the inner cotton portion was designed to absorb cervicovaginal fluid.


Asunto(s)
Biomarcadores/análisis , Cuello del Útero/metabolismo , Técnicas Analíticas Microfluídicas/métodos , Manejo de Especímenes/instrumentación , Vagina/metabolismo , Micropartículas Derivadas de Células/química , Fibra de Algodón , Neoplasias Endometriales/diagnóstico , Neoplasias Endometriales/metabolismo , Femenino , Glucógeno/análisis , Humanos , Concentración de Iones de Hidrógeno , Interleucina-6/análisis , Ácido Láctico/análisis , Persona de Mediana Edad , Papel
4.
Int J Mol Sci ; 14(7): 14270-86, 2013 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-23839095

RESUMEN

Brassinosteroids (BRs) are endogenous plant hormones and are essential for normal plant growth and development. MicroRNAs (miRNAs) of Arabidopsis thaliana are involved in mediating cell proliferation in leaves, stress tolerance, and root development. The specifics of BR mechanisms involving miRNAs are unknown. Using customized miRNA array analysis, we identified miRNAs from A. thaliana ecotype Columbia (Col-0) regulated by 24-epibrassinolide (EBR, a highly active BR). We found that miR395a was significantly up-regulated by EBR treatment and validated its expression under these conditions. miR395a was over expressed in leaf veins and root tissues in EBR-treated miR395a promoter::GUS plants. We integrated bioinformatics methods and publicly available DNA microarray data to predict potential targets of miR395a. GUN5-a multifunctional protein involved in plant metabolic functions such as chlorophyll synthesis and the abscisic acid (ABA) pathway-was identified as a possible target. ABI4 and ABI5, both genes positively regulated by ABA, were down-regulated by EBR treatment. In summary, our results suggest that EBR regulates seedling development and root growth of A. thaliana through miR395a by suppressing GUN5 expression and its downstream signal transduction.


Asunto(s)
Arabidopsis/metabolismo , Brasinoesteroides/farmacología , MicroARNs/biosíntesis , Reguladores del Crecimiento de las Plantas/farmacología , Raíces de Plantas/crecimiento & desarrollo , Transducción de Señal/efectos de los fármacos , Esteroides Heterocíclicos/farmacología , Arabidopsis/genética , Proteínas de Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/genética , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/metabolismo , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Regulación de la Expresión Génica de las Plantas/fisiología , Liasas/genética , Liasas/metabolismo , MicroARNs/genética , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Raíces de Plantas/genética , Transducción de Señal/fisiología , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
5.
J Clin Med ; 10(17)2021 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-34501372

RESUMEN

BACKGROUND: Falling is a major public health concern of elderly people. We aimed to determine if lean mass and spatiotemporal gait parameters could predict the risk of falling in elderly women and also study the relationships between lean mass and gait characteristics. METHODS: Twenty-four community women were prospectively recruited (mean age, 72.30 ± 5.31 years). Lean mass was measured using dual-energy fan-beam X-ray absorptiometry. Gait characteristics were assessed using spatiotemporal analysis. Fall risks were assessed using the Berg Balance Scale (BBS) and the Falls Efficacy Scale-International. Fall histories were recorded. Appropriate statistical analyses were applied to determine lean mass and gait characteristics in predicting the risk of fall and the associations between lean mass and gait characteristics. RESULTS: There were 14 participants (58.33%) with fall histories. Patients with fall histories had a significantly narrower base of support and lower BBS score. However, only the base of support was significantly associated with fall risk (odds ratio, 0.415; p = 0.022). Lean mass was significantly negatively associated with proportion of swing phase and positively associated with proportions of stance and double-support phases. CONCLUSION: Fall risk among elderly women can be predicted using base of support, where a narrower base predicts a greater fall risk. Although the lean mass was not related to risk of fall, lean mass is still related to some gait characteristics.

6.
J Dermatol Sci ; 93(1): 58-64, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30658871

RESUMEN

BACKGROUND: Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown. OBJECTIVES: To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions. METHODS: Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by ß-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections. RESULTS: Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers. CONCLUSIONS: These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.


Asunto(s)
Toxinas Botulínicas Tipo A/farmacología , Degranulación de la Célula/efectos de los fármacos , Eritema/tratamiento farmacológico , Mastocitos/efectos de los fármacos , Rosácea/tratamiento farmacológico , Inhibidores de la Liberación de Acetilcolina , Animales , Péptidos Catiónicos Antimicrobianos/administración & dosificación , Péptidos Catiónicos Antimicrobianos/inmunología , Biopsia , Toxinas Botulínicas Tipo A/uso terapéutico , Degranulación de la Célula/inmunología , Células Cultivadas , Modelos Animales de Enfermedad , Eritema/inmunología , Eritema/patología , Humanos , Inyecciones Intradérmicas , Mastocitos/inmunología , Ratones , Ratones Endogámicos C57BL , Cultivo Primario de Células , Rosácea/inmunología , Rosácea/patología , Piel/citología , Piel/inmunología , Piel/patología , p-Metoxi-N-metilfenetilamina/farmacología , Catelicidinas
7.
J Invest Dermatol ; 139(8): 1743-1752.e5, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30807768

RESUMEN

Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator generated when a cell membrane or its components are damaged by various factors. S1P regulates diverse cell activities via S1P receptors (S1PRs). Keratinocytes express S1PR1-5. Although it is known that S1PRs control keratinocyte differentiation, apoptosis, and wound healing, S1PR functions in keratinocyte infections have not been fully elucidated. We propose that the S1P-S1PR axis in keratinocytes works as a biosensor for bacterial invasion. Indeed, in human impetigo infection, we found high epidermal expression of S1PR1 and S1PR2 in the skin. Furthermore, in normal human epidermal keratinocytes in vitro, treatment with Staphylococcus aureus bacterial supernatant not only induced S1P production but also increased the transcription of S1PR2, confirming our in vivo observation, as well as increased the levels of TNFA, IL36G, IL6, and IL8 mRNAs. However, direct treatment of normal human epidermal keratinocytes with S1P increased the expressions of IL36G, TNFA, and IL8, but not IL6. In both S1P- and S. aureus bacterial supernatant-treated normal human epidermal keratinocytes, S1PR1 knockdown reduced IL36G, TNFA, and IL8 transcription, and the S1PR2 antagonist JTE013 blocked the secretion of these cytokines. Overall, we have proven that during infections, keratinocytes communicate damage by using S1P release and tight control of S1PR1 and 2.


Asunto(s)
Interacciones Huésped-Patógeno/inmunología , Impétigo/inmunología , Queratinocitos/inmunología , Lisofosfolípidos/metabolismo , Piel/inmunología , Esfingosina/análogos & derivados , Células Cultivadas , Citocinas/inmunología , Citocinas/metabolismo , Técnicas de Silenciamiento del Gen , Humanos , Impétigo/microbiología , Impétigo/patología , Queratinocitos/metabolismo , Queratinocitos/microbiología , Cultivo Primario de Células , Pirazoles/farmacología , Piridinas/farmacología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Transducción de Señal/inmunología , Piel/citología , Piel/patología , Esfingosina/metabolismo , Receptores de Esfingosina-1-Fosfato/antagonistas & inhibidores , Receptores de Esfingosina-1-Fosfato/genética , Receptores de Esfingosina-1-Fosfato/metabolismo , Staphylococcus aureus/inmunología
8.
FEBS J ; 281(13): 2990-3003, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24814716

RESUMEN

Irxl1/Mkx (Iroquois homeobox-like 1/Mohawk) encodes a member of the TALE subfamily of homeodomain proteins. It is expressed in multiple mesoderm-derived tissues and has recently been shown to regulate tendon differentiation during mouse embryonic development. Previously we showed that knockdown of Irxl1 in zebrafish caused a deficit in neural crest cells which consequently resulted in deformation of craniofacial muscles and arch cartilages. Here, we further demonstrate that loss of Irxl1 function results in deformed somites with disordered muscle fibers and myotendinous junctions. Because expression of myoD is increased in the somites of Irxl1 knockdown morphants, we test whether Irxl1 negatively regulates myoD expression. When stable C2C12 myoblasts overexpressing Irxl1/Mkx were induced to differentiate, myotube formation was inhibited and protein levels of myoD and myosin heavy chain were decreased accordingly. A series of deletion constructs of myoD promoter fragments were tested by luciferase reporter assays, which identified a promoter fragment that is necessary and sufficient for Irxl1-mediated repression. Direct interaction of Irxl1 and myoD promoter was subsequently elucidated by yeast one-hybrid assays, electrophoretic mobility shift assays and chromatin immunoprecipitation analysis. Furthermore, mouse Mkx also binds to and represses myoD promoter. These results indicate that Irxl1/Mkx can repress myoD expression through direct binding to its promoter and may thus play a negative regulatory role in muscle differentiation.


Asunto(s)
Diferenciación Celular , Proteínas de Homeodominio/fisiología , Proteína MioD/metabolismo , Mioblastos/fisiología , Proteínas de Pez Cebra/fisiología , Animales , Secuencia de Bases , Línea Celular , Secuencia de Consenso , Técnicas de Silenciamiento del Gen , Silenciador del Gen , Ratones , Datos de Secuencia Molecular , Morfolinos/genética , Músculo Esquelético/citología , Músculo Esquelético/fisiología , Proteína MioD/genética , Regiones Promotoras Genéticas , Unión Proteica , Pez Cebra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA